Neurovascular Embolization Devices Market is thriving worldwide by 2029

Neurovascular embolization devices market is anticipated to grow at a CAGR of 6.3% during the forecast period (2023-2030). The market growth is attributed to the increasing prevalence of cerebral aneurysms, and severe risks associated with intracranial aneurysms, such as permanent loss of cognitive functions and neurological disorders. Brain aneurysm is equally prevalent in individuals of all age groups, however individuals 35 years and above are at high risk. According to the Brain Aneurysm Foundation (BAF), an estimated 6.7 million people in the US have an unruptured brain aneurysm or 1 in 50 people. Brain aneurysms are most prevalent in people aged between 35 to 60 years, however it may occur in children as well. Most aneurysms is developed after the age of 40 years. Women are more likely than men to have a brain aneurysm (3:2 ratio). All these factors have compelled manufacturers to introduce novel and cutting-edge neurovascular embolization devices and rising Food and Drug Administration (FDA) clearance globally. For instance, in March 2022, Artio Medical, Inc., a medical device company developing innovative products for the peripheral vascular, neurovascular, and cardiology markets, received US FDA clearance for its solus gold embolization device, a next-generation product for peripheral vascular occlusion.

Get Free Sample link @ https://www.omrglobal.com/request-sample/neurovascular-embolization-devices-market

The global neurovascular embolization devices market is segmented on the product, and end-use. Based on the product, the market is sub-segmented into embolic coils and flow diversion devices. Further, based on end-use, the market is sub-segmented into hospitals and specialty clinics. Among the end-use, the hospitals sub-segment is anticipated to hold a considerable share of the market, owing to the easy availability, offer flexible scheduling options, appealing to individuals with busy lifestyles who are seeking quick and effective treatments.

full report of Neurovascular Embolization Devices Market available @ https://www.omrglobal.com/industry-reports/neurovascular-embolization-devices-market

  • Market Coverage
  • Market number available for – 2023-2029
  • Base year- 2022
  • Forecast period- 2023-2029
  • Segment Covered- By Source, By Product Type, By Applications
  • Competitive Landscape- Archer Daniels Midland Co., Ingredion Inc., Kerry Group Plc, Cargill
  • , and others

Market Segmentation

Global Neurovascular Embolization Devices Market by Product

  • Embolic Coils
  • Flow Diversion Devices

Global Neurovascular Embolization Devices Market by End-Use

  • Hospitals
  • Specialty Clinics

Regional Analysis

  • North America
  • United States
  • Canada
  • Europe
  • UK
  • Germany
  • Italy
  • Spain
  • France
  • Rest of Europe
  • Asia-Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
  • Rest of the World

Company Profiles 

  • Acandis GmbH
  • Balt Extrusion SA
  • Boston Scientific Corp.
  • DePuy Synthes (Johnson & Johnson Services, Inc.)
  • Integra Lifesciences Holdings Corp.
  • MicroVention Inc.
  • Penumbra Inc.
  • Phenox GmbH
  • Resonetics LLC
  • Spartan Micro, Inc.
  • Terumo Medical Corp.

The Report Covers

  • Market value data analysis of 2022 and forecast to 2030.
  • Annualized market revenues ($ million) for each market segment.
  • Country-wise analysis of major geographical regions.
  • Key companies operating in the global neurovascular embolization devices market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
  • Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
  • Analysis of market-entry and market expansion strategies.
  • Competitive strategies by identifying ‘who-stands-where’ in the market.

For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/neurovascular-embolization-devices-market

About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offer Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.

Media Contact:

Company Name: Orion Market Research

Contact Person: Mr. Anurag Tiwari

Email: info@omrglobal.com

Contact no: +91 780-304-0404